-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
At the "2022 Shanghai International Biomedical Industry Week" being held here, the "Digital Healthcare Innovation Forum" was held
on the 6th.
Fan Jia, academician of the Chinese Academy of Sciences and president of Zhongshan Hospital affiliated to Fudan University, said that with the development of the times, the people's demand for medical treatment has changed, and the medical industry will integrate more digital technologies such as 5G and artificial intelligence to make medical services truly intelligent and individualized
.
Academician Fan Jia said: "At present, China's digital medical construction is booming, but there is still a certain gap
with the people's pursuit of high-level medical care.
”
on the 6th.
Fan Jia, academician of the Chinese Academy of Sciences and president of Zhongshan Hospital affiliated to Fudan University, said that with the development of the times, the people's demand for medical treatment has changed, and the medical industry will integrate more digital technologies such as 5G and artificial intelligence to make medical services truly intelligent and individualized
.
Academician Fan Jia said: "At present, China's digital medical construction is booming, but there is still a certain gap
with the people's pursuit of high-level medical care.
”
The forum focuses on the current digital hotspots, is committed to building a platform for promoting academic exchanges, scientific innovation and industrial cooperation in digital healthcare, takes "innovation" as a breakthrough, shares the most cutting-edge trends and clinical application exploration of China's digital medicine, and accelerates Shanghai's construction into a world-class biomedical digital and intelligent development highland
.
.
During the interview, the reporter learned that in recent years, Shanghai has vigorously promoted the development of deep integration of industry and medicine and the digital transformation
of the biomedical field.
The shortlist of "Personalized Medicine Incubation Project" of the "Precision Medicine Research and Industrial Innovation Development Fund" in 2022 was "released", and 10 clinical research projects with translational prospects in the fields of oncology, Alzheimer's disease and ophthalmology were selected, including 4 projects
led by Shanghai experts.
of the biomedical field.
The shortlist of "Personalized Medicine Incubation Project" of the "Precision Medicine Research and Industrial Innovation Development Fund" in 2022 was "released", and 10 clinical research projects with translational prospects in the fields of oncology, Alzheimer's disease and ophthalmology were selected, including 4 projects
led by Shanghai experts.
Professor Gu Yajia, Director of the Department of Diagnostic Radiology, Fudan University Cancer Hospital, was shortlisted
for related projects.
She introduced the research progress and transformation
of tumor imaging AI in the fields of breast, lung, colorectal and gynecological tumors.
Regarding the individualized medical projects that have just been shortlisted, she said: "We expect to promote predictive models to different immunotherapy regimens through large-scale clinical verification and testing, and continuously iterate algorithms and develop software products to achieve clinical translation and application, and assist clinicians in formulating personalized treatment plans
.
" The related projects led by Professor Sun Huichuan, Deputy Director of the Department of Liver Surgery, Zhongshan Hospital Affiliated to Fudan University, are also shortlisted projects
.
On the same day, he started from the current dilemma of liver cancer diagnosis and treatment in China and shared the hospital's efforts
to promote the construction of a standardized whole-process diagnosis and treatment system for liver cancer through digital means.
Professor Sun Huichuan said: "In the future, the hospital will continue to strengthen cooperation between hospitals and enterprises and build a collaborative innovation ecological development system
.
for related projects.
She introduced the research progress and transformation
of tumor imaging AI in the fields of breast, lung, colorectal and gynecological tumors.
Regarding the individualized medical projects that have just been shortlisted, she said: "We expect to promote predictive models to different immunotherapy regimens through large-scale clinical verification and testing, and continuously iterate algorithms and develop software products to achieve clinical translation and application, and assist clinicians in formulating personalized treatment plans
.
" The related projects led by Professor Sun Huichuan, Deputy Director of the Department of Liver Surgery, Zhongshan Hospital Affiliated to Fudan University, are also shortlisted projects
.
On the same day, he started from the current dilemma of liver cancer diagnosis and treatment in China and shared the hospital's efforts
to promote the construction of a standardized whole-process diagnosis and treatment system for liver cancer through digital means.
Professor Sun Huichuan said: "In the future, the hospital will continue to strengthen cooperation between hospitals and enterprises and build a collaborative innovation ecological development system
.
In fact, personalized medicine uses digitalization as a means to maximize the impact of limited health resources
.
The reporter learned that the "Precision Medicine Research and Industry Innovation Development Fund - Personalized Medicine Incubation Project" was launched in Shanghai, aiming to create a precision medicine "research-incubation-training" ecology to enrich the development of digital products in the medical field and promote medical innovation and the transformation
of scientific research achievements.
The project is jointly supported
by Shanghai Medical Innovation and Development Foundation and Roche Pharma China.
Li Bin, Vice President of Medicine and Personalized Medicine in China, said that "through a wealth of personalized medical products, we can provide rich digital solutions on top of 'diagnosis' and 'treatment' to benefit patients
.
As a multinational enterprise deeply involved in and witnessing the development of Shanghai's biopharmaceutical industry, Bian Xin, President of Roche Pharmaceuticals China, pointed out that Shanghai's focus on the development of digitally-enabled industries and the establishment of a world-class biomedical industry cluster need to continue to give full play to the advantages of high-level openness and innovation, achieve more policy breakthroughs, more enabling medical infrastructure, and a more level playing field
.
.
The reporter learned that the "Precision Medicine Research and Industry Innovation Development Fund - Personalized Medicine Incubation Project" was launched in Shanghai, aiming to create a precision medicine "research-incubation-training" ecology to enrich the development of digital products in the medical field and promote medical innovation and the transformation
of scientific research achievements.
The project is jointly supported
by Shanghai Medical Innovation and Development Foundation and Roche Pharma China.
Li Bin, Vice President of Medicine and Personalized Medicine in China, said that "through a wealth of personalized medical products, we can provide rich digital solutions on top of 'diagnosis' and 'treatment' to benefit patients
.
As a multinational enterprise deeply involved in and witnessing the development of Shanghai's biopharmaceutical industry, Bian Xin, President of Roche Pharmaceuticals China, pointed out that Shanghai's focus on the development of digitally-enabled industries and the establishment of a world-class biomedical industry cluster need to continue to give full play to the advantages of high-level openness and innovation, achieve more policy breakthroughs, more enabling medical infrastructure, and a more level playing field
.
Fan Jia hopes that through the sharing of this forum, it can promote the deep integration of digital technology in the medical and health field, accelerate the digital transformation process of Shanghai's medical industry, and benefit the people
.
(End)
.
(End)
